280 related articles for article (PubMed ID: 18261355)
1. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
[TBL] [Abstract][Full Text] [Related]
2. [Long-term hemodialysis and changes in variables of coagulation and fibrinolysis].
Uchida Y
Fukuoka Igaku Zasshi; 1991 Nov; 82(11):576-85. PubMed ID: 1774013
[TBL] [Abstract][Full Text] [Related]
3. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
[TBL] [Abstract][Full Text] [Related]
4. Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism.
Grimaudo V; Bachmann F; Hauert J; Christe MA; Kruithof EK
Thromb Haemost; 1992 Apr; 67(4):397-401. PubMed ID: 1631786
[TBL] [Abstract][Full Text] [Related]
5. [Levels of tissue-type plasminogen activator and plasminogen activator inhibitor 1 in disseminated intravascular coagulation syndrome].
Fukao H; Yamamoto K; Matsuo O
Rinsho Byori; 1991 Jul; 39(7):720-6. PubMed ID: 1920864
[TBL] [Abstract][Full Text] [Related]
6. [An experimental study of local fibrinolysis using tissue plasminogen activator and urokinase in a canine common carotid artery thrombus model].
Kawakami K; Takahashi A; Yoshimoto T
No To Shinkei; 1990 Feb; 42(2):193-201. PubMed ID: 2113401
[TBL] [Abstract][Full Text] [Related]
7. [The changes in molecular markers for hemostatic activation after t-PA therapy in case of pulmonary embolism].
Masuoka H; Hiraoka N; Inden M; Fujioka H; Konishi T; Nakano T; Deguchi K
Kokyu To Junkan; 1992 Apr; 40(4):407-10. PubMed ID: 1315073
[TBL] [Abstract][Full Text] [Related]
8. On the fibrinolytic system in aged rats, and its reactivity to endotoxin and cytokines.
Emeis JJ; Brouwer A; Barelds RJ; Horan MA; Durham SK; Kooistra T
Thromb Haemost; 1992 Jun; 67(6):697-701. PubMed ID: 1509412
[TBL] [Abstract][Full Text] [Related]
9. Fibrinolytic effect of a particular glycosaminoglycan (endoglycan) per os on normals and in patients with chronic artery disease.
Patrassi GM; Veronesi A; Sartori MT; Viero ML; Boeri G; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(3):369-76. PubMed ID: 1703105
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal fluid and plasma fibrinolytic activity in women with pelvic inflammatory disease.
Dörr PJ; Brommer EJ; Dooijewaard G; Vemer HM
Thromb Haemost; 1992 Aug; 68(2):102-5. PubMed ID: 1412151
[TBL] [Abstract][Full Text] [Related]
11. [A clinical study on hemostatic fluctuation during and after cardiopulmonary bypass using hemostatic molecular markers].
Nakajima H
Nihon Kyobu Geka Gakkai Zasshi; 1992 Nov; 40(11):1987-97. PubMed ID: 1336789
[TBL] [Abstract][Full Text] [Related]
12. Changes and significance of the fibrinolytic system following two pulmonary thromboembolisms in a rabbit model.
Liu DC; Duan B; Zhao MN; Wu L; Cao YZ; Liu NB; Xue Z; He ZH; Mi J
J Physiol Pharmacol; 2024 Apr; 75(2):137-144. PubMed ID: 38736261
[TBL] [Abstract][Full Text] [Related]
13. The action of propionyl-L-carnitine on the vasal endothelium: increased t-PA synthesis and a decrease in the activity of PAI-1. A preliminary study.
Pola P; De Martini D; Gerardino L; De Rossi S; Tondi P
Drugs Exp Clin Res; 1992; 18(8):343-8. PubMed ID: 1292917
[TBL] [Abstract][Full Text] [Related]
14. [Blood coagulation and fibrinolysis in patients with Behçet's disease].
Fusegawa H; Ichikawa Y; Tanaka Y; Miyachi Y; Kawada T; Gondo K; Ikeda M; Shimizu H; Arimori S; Ando Y
Rinsho Byori; 1991 May; 39(5):509-16. PubMed ID: 2072574
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor-1 suppresses endogenous fibrinolysis in a canine model of pulmonary embolism.
Reilly CF; Fujita T; Hutzelmann JE; Mayer EJ; Shebuski RJ
Circulation; 1991 Jul; 84(1):287-92. PubMed ID: 1905594
[TBL] [Abstract][Full Text] [Related]
16. Fibrinolytic potential and antiphospholipid antibodies in systemic lupus erythematosus and other connective tissue disorders.
Jurado M; Páramo JA; Gutierrez-Pimentel M; Rocha E
Thromb Haemost; 1992 Nov; 68(5):516-20. PubMed ID: 1455397
[TBL] [Abstract][Full Text] [Related]
17. [Effect of high-dose medroxyprogesterone acetate on coagulative and fibrinolytic factors in patients with gynecological cancers].
Ishizaki T; Itoh R; Yasuda J; Yamamoto T; Okada H
Gan To Kagaku Ryoho; 1992 Jun; 19(6):837-42. PubMed ID: 1534983
[TBL] [Abstract][Full Text] [Related]
18. Coagulation and fibrinolytic activity in Behçet's disease.
Hampton KK; Chamberlain MA; Menon DK; Davies JA
Thromb Haemost; 1991 Sep; 66(3):292-4. PubMed ID: 1745999
[TBL] [Abstract][Full Text] [Related]
19. [A new advance in theory of blood coagulation and fibrinolysis and its practical application].
Matsuno K; Araki K
Rinsho Byori; 1991 Feb; 39(2):179-84. PubMed ID: 1904112
[TBL] [Abstract][Full Text] [Related]
20. [Local low dosage thrombolysis with rt-PA. Systemic effects on the fibrinolytic system--data on the assessment of the value and risk of this method].
von Bilderling P; Spannagl M; Mietaschk A; Iven M; Schramm W; Hess H
Vasa Suppl; 1991; 33():132-3. PubMed ID: 1788645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
